14-Mar-18, Asia-Pacific Biotech News
As healthcare systems across Asia face pressure from rising costs, many countries are considering a shift towards value-based healthcare (VBHC) policies. This has implications for the medtech industry, which is a key part of the value equation.
%20Asia-Pacific%20Biotech%20News.jpg "What value based healthcare means for Asia (c) Asia Pacific Biotech News")
Image: Asia-Pacific Biotech News
Innovative and collaborative approaches to product development, market access, and commercial excellence will become increasingly necessary.
While most countries are still working to build the technological and professional capacity to make VBHC a reality, a few are actively experimenting with VBHC pilots. .